Log In
Print
BCIQ
Print
Print this Print this
 

Forfivo XL bupropion (CPI-300, INT0004)

  Manage Alerts
Collapse Summary General Information
Company IntelGenx Corp.
DescriptionOral antidepressant containing a high strength formulation of bupropion developed using IntelGenx's controlled-release drug delivery technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationDepression
Indication DetailsTreat major depressive disorder (MDD)
Regulatory Designation

Partner

Edgemont Pharmaceuticals LLC


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today